Cargando…

Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors

Condensed-bicyclic triazolo-thiadiazoles were synthesized via an efficient “green” catalyst strategy and identified as effective inhibitors of PTP1B in vitro. The lead compound, 6-(2-benzylphenyl)-3-phenyl-[1,2,4]triazolo[3][1,3,4]thiadiazole (BPTT) was most effective against human hepatoma cells, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Baburajeev, C. P., Dhananjaya Mohan, Chakrabhavi, Ananda, Hanumappa, Rangappa, Shobith, Fuchs, Julian E., Jagadish, Swamy, Sivaraman Siveen, Kodappully, Chinnathambi, Arunachalam, Ali Alharbi, Sulaiman, Zayed, M. E., Zhang, Jingwen, Li, Feng, Sethi, Gautam, Girish, Kesturu S., Bender, Andreas, Basappa, Rangappa, Kanchugarakoppal S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585680/
https://www.ncbi.nlm.nih.gov/pubmed/26388336
http://dx.doi.org/10.1038/srep14195
_version_ 1782392252286369792
author Baburajeev, C. P.
Dhananjaya Mohan, Chakrabhavi
Ananda, Hanumappa
Rangappa, Shobith
Fuchs, Julian E.
Jagadish, Swamy
Sivaraman Siveen, Kodappully
Chinnathambi, Arunachalam
Ali Alharbi, Sulaiman
Zayed, M. E.
Zhang, Jingwen
Li, Feng
Sethi, Gautam
Girish, Kesturu S.
Bender, Andreas
Basappa,
Rangappa, Kanchugarakoppal S.
author_facet Baburajeev, C. P.
Dhananjaya Mohan, Chakrabhavi
Ananda, Hanumappa
Rangappa, Shobith
Fuchs, Julian E.
Jagadish, Swamy
Sivaraman Siveen, Kodappully
Chinnathambi, Arunachalam
Ali Alharbi, Sulaiman
Zayed, M. E.
Zhang, Jingwen
Li, Feng
Sethi, Gautam
Girish, Kesturu S.
Bender, Andreas
Basappa,
Rangappa, Kanchugarakoppal S.
author_sort Baburajeev, C. P.
collection PubMed
description Condensed-bicyclic triazolo-thiadiazoles were synthesized via an efficient “green” catalyst strategy and identified as effective inhibitors of PTP1B in vitro. The lead compound, 6-(2-benzylphenyl)-3-phenyl-[1,2,4]triazolo[3][1,3,4]thiadiazole (BPTT) was most effective against human hepatoma cells, inhibits cell invasion, and decreases neovasculature in HUVEC and also tumor volume in EAT mouse models. This report describes an experimentally unidentified class of condensed-bicyclic triazolo-thiadiazoles targeting PTP1B and its analogs could be the therapeutic drug-seeds.
format Online
Article
Text
id pubmed-4585680
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-45856802015-09-29 Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors Baburajeev, C. P. Dhananjaya Mohan, Chakrabhavi Ananda, Hanumappa Rangappa, Shobith Fuchs, Julian E. Jagadish, Swamy Sivaraman Siveen, Kodappully Chinnathambi, Arunachalam Ali Alharbi, Sulaiman Zayed, M. E. Zhang, Jingwen Li, Feng Sethi, Gautam Girish, Kesturu S. Bender, Andreas Basappa, Rangappa, Kanchugarakoppal S. Sci Rep Article Condensed-bicyclic triazolo-thiadiazoles were synthesized via an efficient “green” catalyst strategy and identified as effective inhibitors of PTP1B in vitro. The lead compound, 6-(2-benzylphenyl)-3-phenyl-[1,2,4]triazolo[3][1,3,4]thiadiazole (BPTT) was most effective against human hepatoma cells, inhibits cell invasion, and decreases neovasculature in HUVEC and also tumor volume in EAT mouse models. This report describes an experimentally unidentified class of condensed-bicyclic triazolo-thiadiazoles targeting PTP1B and its analogs could be the therapeutic drug-seeds. Nature Publishing Group 2015-09-21 /pmc/articles/PMC4585680/ /pubmed/26388336 http://dx.doi.org/10.1038/srep14195 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Baburajeev, C. P.
Dhananjaya Mohan, Chakrabhavi
Ananda, Hanumappa
Rangappa, Shobith
Fuchs, Julian E.
Jagadish, Swamy
Sivaraman Siveen, Kodappully
Chinnathambi, Arunachalam
Ali Alharbi, Sulaiman
Zayed, M. E.
Zhang, Jingwen
Li, Feng
Sethi, Gautam
Girish, Kesturu S.
Bender, Andreas
Basappa,
Rangappa, Kanchugarakoppal S.
Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
title Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
title_full Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
title_fullStr Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
title_full_unstemmed Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
title_short Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors
title_sort development of novel triazolo-thiadiazoles from heterogeneous “green” catalysis as protein tyrosine phosphatase 1b inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585680/
https://www.ncbi.nlm.nih.gov/pubmed/26388336
http://dx.doi.org/10.1038/srep14195
work_keys_str_mv AT baburajeevcp developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT dhananjayamohanchakrabhavi developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT anandahanumappa developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT rangappashobith developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT fuchsjuliane developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT jagadishswamy developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT sivaramansiveenkodappully developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT chinnathambiarunachalam developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT alialharbisulaiman developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT zayedme developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT zhangjingwen developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT lifeng developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT sethigautam developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT girishkesturus developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT benderandreas developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT basappa developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors
AT rangappakanchugarakoppals developmentofnoveltriazolothiadiazolesfromheterogeneousgreencatalysisasproteintyrosinephosphatase1binhibitors